Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity

Human Immunology

Volumn 55, Issue 2, 1997, Pages 148-153

  Jackson, Annette ^a   McSherry, Cynthia ^a   Butters, Kim ^a   Diko, Michael ^a   Almond, P Stephen ^b   Matas, Arthur J ^a   Reinsmoen, Nancy L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; BLOOD TRANSFUSION; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOMODULATION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

BLOOD TRANSFUSION; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; TISSUE DONORS;

EID: 0030700503     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00098-0     Document Type: Article

References (31)

1. Salvatierra O Jr, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ. Deliberate donor-specific blood transfusions prior to living related renal transplantation A new approach . Ann Surg. 192:1980;544.
2. Opelz G, Terasaki PI. Dominant effect of transfusions on kidney graft survival. Transplantation. 29:1980;153.
3. Kahan BD, Van Buren CT, Flechner SM, Payne WD, Boileau M, Kerman RH. Cyclosporine immunosuppression mitigates immunologic risk factors in renal allotransplantation. Transplant Proc. 15:1983;2469.
4. Lundgren G, Albrechtsen D, Flatmark A, Gäbel H, Klintmalm G, Persson H, Groth CG, Brynger H, Frödin L, Husberg B, Maurer W, Thorsby E. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation - A changing picture with cyclosporin. Lancet. 2:1986;66.
5. Opelz G. Improved kidney graft survival in nontransfused recipients. Transplant Proc. 19:1987;149.
6. Cecka JM, Cicciarelli J, Mickey MR, Terasaki PI. Blood transfusions and HLA matching - An either/or situation in cadaveric renal transplantation. Transplantation. 45:1988;81.
7. Iwaki Y, Cecka JM, Terasaki PI. The transfusion effect in cadaver kidney transplants - Yes or no. Transplantation. 49:1990;56.
8. Chertow GM, Milford EL. Pre-transplant blood transfusion and cadaveric renal allograft outcome Data from the United Network of Organ Sharing (UNOS) . J Am Soc Nephol. 16:1995;1077.
9. Kerman RH, Susskind B, Katz SM, Van Buren CT, Kahan BD. Post renal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders. Transplant Proc. 29:1997;1410.
10. Kerman RH, Katz SM, Schoenberg L, Baraket O, Van Buren CT, Kahan BD. 10 year follow up of MLR-hyporesponsive living related cyclosporine monotherapy treated renal allograft recipients. Transplant Proc. 29:1997;198.
11. Reinsmoen NL, Matas AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation. 55:1993;1017.
12. Reinsmoen NL, Bolman RM, Savik K, Butters K, Matas AJ, Hertz MI. Improved graft outcome in lung transplantation recipients who develop donor antigen-specific hyporeactivity. J Heart Lung Transplant. 13:1994;30.
13. Reinsmoen NL, Hertz MI, Kubo S, Bolman RM, Matas AJ. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity. Transplantation Proc. 26:1994;2558.
14. Reinsmoen NL, Hertz MI, Kubo SH, Bolman RM, Matas AJ. Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplants. Transplantation Proc. 25:1993;3277.
15. Esquenazi V, Gomez C, Gharagozloo H: Antibody Screening. In Nikaein A, (ed): ASHI Laboratory Manuel 3rd Edition. Section I.D.2.1.
16. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:1988;487.
17. Baxter-Lowe L: HLA-DR and HLA-DQ oligotyping. In Nikaein A, (ed): ASHI Laboratory Manuel 3rd Edition. Section IV.C.1.1.
18. Reinsmoen NL, Kaufman D, Matas A, Sutherland DER, Najarian JS, Bach FH. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation. 50:1990;783.
19. Pistillo MP, Sun PF, Mantero S, Ferrara GB. Shared epitopes of the HLA-DR10 molecule recognized by murine and human mAbs. Eur J Immunogenet. 20:1993;111.
20. Mickelson E, Sterkers G, Zeevi A, Termijtelen A, Farrell C, Honeyman M, Hansen JA, Eckels D, Reinsmoen N, Flomenberg N. DRw6 Antigen report of the cellular studies of the Tenth International Histocompatibility Workshop . Dupont B. Immunobiology of HLA Volume I. 1989;Springer-Verlag, New York.
21. Burlingham WJ, Grailer A, Sondel PM, Sollinger HW. Improved renal allograft survival following donor-specific transfusions. Transplantation. 45:1988;127.
22. Bean MA, Mickelson E, Yanagida J, Ishioka S, Brannen GE, Hansen JA. Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipients noninherited maternal HLA haplotype. Transplantation. 49:1990;382.
23. van Twuyver E, Mooijaart RJD, Ten Berge IJM, van der Horst AR, Wilmink JM, Kast WM, Melief CJM, de Waal LP. Pretransplantation blood transfusion revisited. N Engl J Med. 325:1991;1210.
24. Terasaki PI. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation. 37:1984;119.
25. Leivestad T, Thorsby E. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation. 37:1984;175.
26. Suciu-Foca N, Reed E, Rohowsky C, Kung P, King DW. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Immunology. 80:1983;830.
27. McSherry C, Jackson A, Hertz MI, Bolman RM III, Savik K, Reinsmoen NL. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. Transplantation. 62:1996;1811.
28. Zeevi A, Pavlick M, Banas R, Bentlejewski C, Spichty K, Rao AS, Fontes P, Iyengar A, Shapiro R, Dodson F, Jordon M, Pham S, Keenan R, Griffith B, Corry R, Egidi F, Fung JJ, Starzl TE. Three years of follow-up of bone marrow-augmented organ transplant recipients The impact on donor-specific immune modulation . Transplant Proc. 29:1997;1205.
29. Lagaaij EL, Hennemann IPH, Ruigrok M, De Haan MW, Persijn GG, Termijtelen A, Hendriks GFJ, Weimar W, Claas FHJ, van Rood JJ. N Engl J Med. 321:1989;701.
30. Bućin D. Adverse effect of blood transfusion on the long-term outcome of kidney transplantation. Expl Clin Immunogenet. 5:1988;39.
31. de Waal LP, van Twyver E. Blood tranfusion and allograft survival Is mixed chimerism the solution for tolerance induction in clinical transplantation? Crit Rev Immunol. 10:1991;417.